President-elect Donald Trump announced Thursday he plans to nominate Robert F. Kennedy Jr. to head the Department of Health ...

Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.

Pharmaceutical stocks slumped as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...

His ideas may sound good on bumper stickers but are unserious and often downright harmful,” Dr. Ashish K. Jha, dean of Brown ...

Pharma and biotech stocks are down due to concerns over Robert F. Kennedy Jr. possibly taking the helm at HHS. Read more here ...

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

Kennedy has pledged to "return our health agencies to their rich tradition of gold-standard, evidence-based science." ...

Kennedy Jr.'s nomination has been met with outrage from doctors, but it's not clear if he will disrupt immunization programs.

Healthcare stocks in the S&P 500 were headed for their worst week since 2020 on Friday. President-elect Donald Trump's decision to nominate vaccine skeptic RFK Jr. to lead the Department of Health and ...

“Somebody said to me today, ‘I can’t think of any single individual who would be more damaging to public health than RFK,'" ...

President-elect Donald Trump picks prominent vaccine skeptic to lead the nation’s sprawling public health apparatus.

Bavarian Nordic, a maker of the mpox vaccine, on Friday said the incoming Trump administration may present opportunities even ...